Active ingredientHalofantrine HydrochlorideCat. No. P-H003-001CAS 36167-63-2Family · Pharmaceutical analytical standards
Halofantrine
A phenanthrene antimalarial, related to quinine and lumefantrine, developed in the United States between 1965 and 1975; it is used only to treat malaria, not to prevent it. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?Its absorption is erratic and increases with fatty food: an example of how a meal can change the amount of medicine that reaches the blood.
Go to the active ingredient →Active ingredientHalofantrine HydrochlorideCat. No. P-H003-001CAS 36167-63-2
Pharmacopoeial impurityHalofantrine EP Impurity CCat. No. P-H003-002CAS 38492-81-8
ImpurityHalofantrine N-OxideCat. No. P-H003-003CAS 1348409-88-0No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceHalofantrine hydrochloride CRSEDQM code Y0000117Family HalofantrineImpurityHalofantrine impurity C CRSEDQM code Y0000118Family HalofantrineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.